Tofacitinib and risk of cardiovascular outcomes: results from the Safety of Tofacitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
Rheumatol Ther. 2021. Epub ahead of print. doi: 10.1007/s40744-021-00390-0
Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861
Please click the links below to go to the CSF review of each paper
Rheumatology (Oxford). 2021;60(7):3209–21
Ann Rheum Dis. 2021 May 28. DOI: 10.1136/annrheumdis-2021-220418
RMD Open. 2021;7(2):e001601.
Arthritis Care Res (Hoboken). 2021;73(4):481-488.
Arthritis Res Ther. 2021;23(1):53.
Ann Rheum Dis. 2021 Jan 27:annrheumdis-2020-219214